AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 75 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,630 | +100.7% | 29,500 | +61.1% | 0.02% | +142.9% |
| Q2 2023 | $16,759 | +63.3% | 18,316 | 0.0% | 0.01% | +40.0% |
| Q1 2023 | $10,264 | -2.9% | 18,316 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $10,568 | +76.1% | 18,316 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $6,000 | 0.0% | 18,316 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | -57.1% | 18,316 | -2.7% | 0.00% | -42.9% |
| Q1 2022 | $14,000 | – | 18,828 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
| Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
| WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
| Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |